Literature DB >> 25120807

Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer.

Jia-Yu Yin1, Zhao-Qun Deng1, Feng-Qiong Liu2, Jun Qian1, Jiang Lin1, Qin Tang1, Xiang-Mei Wen1, Jing-Dong Zhou1, Ying-Ying Zhang1, Xiao-Wen Zhu1.   

Abstract

BACKGROUND: MiR-24/378 is thought to be onco-miRNAs for their ability of enhancing tumor growth. The objective of this study was to evaluate the potential predictive value of miR-24/378 expression in formalin-fixed paraffin-embedded tissues of breast cancer patients.
METHODS: The expression of miR-24/378 was examined in 101 breast cancer patients and 40 controls using real-time quantitative PCR. All statistical analyses were performed using SPSS16.0.
RESULTS: We found that miR-24 and miR-378 were significantly up-regulated in breast cancer patients compared with controls (all P < 0.01). The expression levels of the two miRNAs were highly correlated with each other in breast cancer patients, with r = 0.778 between miR-24 and miR-378. Moreover, the two miRNAs exhibited great capability of discriminating between cancer patients and controls by ROC analysis. MiR-24 and miR-378 showed 0.79 and 0.807 AUC values respectively.
CONCLUSIONS: Over-expression of miR-24 and miR-378 in FFPE tissue of breast cancer patients might conduct as an ideal source for biomarker discovery and validation in breast cancer patients.

Entities:  

Keywords:  Biomarkers; breast cancer; formalin-fixed paraffin-embedded; miR-24; miR-378

Mesh:

Substances:

Year:  2014        PMID: 25120807      PMCID: PMC4129042     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  36 in total

1.  MicroRNA-binding viral protein interferes with Arabidopsis development.

Authors:  Padmanabhan Chellappan; Ramachandran Vanitharani; Claude M Fauquet
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

2.  miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.

Authors:  Shu-Chun Lin; Chung-Ji Liu; Jung-An Lin; Wei-Fan Chiang; Pei-Shih Hung; Kuo-Wei Chang
Journal:  Oral Oncol       Date:  2010-02-06       Impact factor: 5.337

3.  Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer.

Authors:  Tindara Franchina; Valeria Amodeo; Giuseppe Bronte; Giuseppina Savio; Giuseppina R R Ricciardi; Maria Picciotto; Antonio Russo; Antonio Giordano; Vincenzo Adamo
Journal:  J Cell Physiol       Date:  2014-01       Impact factor: 6.384

4.  Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia.

Authors:  Jun Qian; Jiang Lin; Wei Qian; Ji-chun Ma; Si-xuan Qian; Yun Li; Jing Yang; Jian-yong Li; Cui-zhu Wang; Hai-yan Chai; Xing-xing Chen; Zhao-qun Deng
Journal:  Leuk Res       Date:  2013-04-11       Impact factor: 3.156

5.  Nuclear export of microRNA precursors.

Authors:  Elsebet Lund; Stephan Güttinger; Angelo Calado; James E Dahlberg; Ulrike Kutay
Journal:  Science       Date:  2003-11-20       Impact factor: 47.728

6.  MicroRNAs in human cancer: from research to therapy.

Authors:  Massimo Negrini; Manuela Ferracin; Silvia Sabbioni; Carlo M Croce
Journal:  J Cell Sci       Date:  2007-06-01       Impact factor: 5.285

7.  Over-expression of miR-98 in FFPE tissues might serve as a valuable source for biomarker discovery in breast cancer patients.

Authors:  Zhao-Qun Deng; Jia-Yu Yin; Qin Tang; Feng-Qiong Liu; Jun Qian; Jiang Lin; Rui Shao; Ming Zhang; Li He
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

8.  The intermediate filament vimentin mediates microRNA miR-378 function in cellular self-renewal by regulating the expression of the Sox2 transcription factor.

Authors:  Zhaoqun Deng; William W Du; Ling Fang; Sze Wan Shan; Jun Qian; Jiang Lin; Wei Qian; Jichun Ma; Zina Jeyapalan Rutnam; Burton B Yang
Journal:  J Biol Chem       Date:  2012-11-07       Impact factor: 5.157

9.  Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.

Authors:  Martina Redova; Alexandr Poprach; Jana Nekvindova; Robert Iliev; Lenka Radova; Radek Lakomy; Marek Svoboda; Rostislav Vyzula; Ondrej Slaby
Journal:  J Transl Med       Date:  2012-03-22       Impact factor: 5.531

10.  MiR-93 enhances angiogenesis and metastasis by targeting LATS2.

Authors:  Ling Fang; William W Du; Weining Yang; Zina Jeyapalan Rutnam; Chun Peng; Haoran Li; Yunxia Q O'Malley; Ryan W Askeland; Sonia Sugg; Mingyao Liu; Tanvi Mehta; Zhaoqun Deng; Burton B Yang
Journal:  Cell Cycle       Date:  2012-10-30       Impact factor: 4.534

View more
  13 in total

1.  MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6.

Authors:  Li Deng; Hui Liu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.

Authors:  Ya-Kai Huang; Jian-Chun Yu
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

3.  Over-expression of miR-675 in formalin-fixed paraffin-embedded (FFPE) tissues of breast cancer patients.

Authors:  Ling-Ling Zhai; Peng Wang; Ling-Yu Zhou; Jia-Yu Yin; Qin Tang; Tin-Juan Zhang; Yu-Xin Wang; Dong-Qin Yang; Jiang Lin; Zhao-Qun Deng
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  Increased expression of miR-24 is associated with acute myeloid leukemia with t(8;21).

Authors:  Jia-Yu Yin; Qin Tang; Wei Qian; Jun Qian; Jiang Lin; Xiang-Mei Wen; Jing-Dong Zhou; Ying-Ying Zhang; Xiao-Wen Zhu; Zhao-Qun Deng
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

5.  Elevated levels of both microRNA 378 (miR-378) and kallikrein-related peptidase 4 (KLK4) mRNA are associated with an unfavorable prognosis in triple-negative breast cancer.

Authors:  Weiwei Gong; Caixia Zhu; Yueyang Liu; Alexander Muckenhuber; Holger Bronger; Andreas Scorilas; Marion Kiechle; Julia Dorn; Viktor Magdolen; Tobias Dreyer
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 6.  Versatile role of miR-24/24-1*/24-2* expression in cancer and other human diseases.

Authors:  Sanjukta Mukherjee; Bhagyashree Shelar; Sudhir Krishna
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

7.  MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.

Authors:  Gillian Browne; Julie A Dragon; Deli Hong; Terri L Messier; Jonathan A R Gordon; Nicholas H Farina; Joseph R Boyd; Jennifer J VanOudenhove; Andrew W Perez; Sayyed K Zaidi; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Tumour Biol       Date:  2016-01-09

8.  Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.

Authors:  Bing Li; Yilin Wang; Shiting Li; Hua He; Fengbin Sun; Chunlin Wang; Yicheng Lu; Xiaoqiang Wang; Bangbao Tao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

9.  Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects.

Authors:  Federica Mori; Maria Ferraiuolo; Raffaela Santoro; Andrea Sacconi; Frauke Goeman; Matteo Pallocca; Claudio Pulito; Etleva Korita; Maurizio Fanciulli; Paola Muti; Giovanni Blandino; Sabrina Strano
Journal:  Oncotarget       Date:  2016-04-12

10.  Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9.

Authors:  Jian-Ping Gong; Liu Yang; Jun-Wei Tang; Peng Sun; Qing Hu; Jian-Wei Qin; Xiao-Ming Xu; Bei-Cheng Sun; Jin-Hai Tang
Journal:  Oncol Lett       Date:  2016-09-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.